Stock Information
Autolus Therapeutics PLC (AUTL)
Ticker Symbol: AUTL
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $375.26 mil
Piotroski score: 4
PE Ratio: N/A
EPS (TTM): -1.0803
Revenue (TTM): $0.28 M
Dividend Yield: N/A%
ROE: -99.05%
Latest News
-
Asgard Therapeutics Appoints Wolfram Brugger as Chief Medical Officer
Tue, Apr 14, 2026 11:38 AM
-
Autolus Therapeutics : Presentation - (260409 autl corporate presentation april 2026)
Mon, Apr 13, 2026 9:00 AM
-
Autolus Therapeutics Files Shelf Prospectus For Offering Of Up To $150 Million Of Securities
Mon, Apr 13, 2026 6:12 AM
Key Financials
Financial data not available
